Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).
about
Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociceptionEicosanoid storm in infection and inflammationMechanism of the sex difference in endothelial dysfunction after strokeGamma-linolenic and stearidonic acids are required for basal immunity in Caenorhabditis elegans through their effects on p38 MAP kinase activityCytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolismThe role of long chain fatty acids and their epoxide metabolites in nociceptive signalingThe role of epoxyeicosatrienoic acids in the cardiovascular systemStabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerEstrogen, aging and the cardiovascular systemSoluble epoxide hydrolase inhibitors and heart failureDevelopment of fluorescent substrates for microsomal epoxide hydrolase and application to inhibition studiesPharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammationAlteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolaseSoluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single AgentBioactive lipid profiling reveals drug target engagement of a soluble epoxide hydrolase inhibitor in a murine model of tobacco smoke exposureProtective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channelsEpoxyeicosanoid signaling in CNS function and diseaseOmeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain modelPeripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptiveAltered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injuryInhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine modelPotent natural soluble epoxide hydrolase inhibitors from Pentadiplandra brazzeana baillon: synthesis, quantification, and measurement of biological activities in vitro and in vivoArachidonate Epoxygenase / Epoxide HydrolaseHPD: an online integrated human pathway database enabling systems biology studies.Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.Rationally designed multitarget agents against inflammation and pain.Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids.Epoxyeicosatrienoic acids are endogenous regulators of vasoactive neuropeptide release from trigeminal ganglion neuronsPost-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxicationTemporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP.Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors.Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures.Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology.20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptorEffects of soluble epoxide hydrolase deficiency on acute pancreatitis in miceSoluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice.
P2860
Q24628660-22E2C6D0-7CF0-4B59-802F-F59A9ECE2FE8Q26851985-E695A3C8-701D-40B7-AC17-20A524008DB9Q27001603-959EF899-481D-40F3-983F-4DC0DB8BE981Q27313549-88A2DAEA-9663-497D-A87D-8B7594FD0615Q28245279-F8FF3F1D-36C8-4D5F-9E2A-F69EE1ABABE7Q28248377-A9DC45FA-0AF4-4B76-950B-7F40947B34F4Q28256560-53158C91-E6C2-4A6B-A89C-540A3CA4E167Q28304230-42D87AA4-2847-4036-B549-68AC4BDB6CF0Q28383144-566887AD-816F-4F62-BE18-78A9AE6266F2Q28383423-BE1346BA-F125-4EEA-9B12-132336B36B19Q28388362-AD5A3751-423B-4B07-8A85-70D9AD80D5A1Q28389323-E03FE6E2-E321-45B1-B81E-35293DF57523Q28390217-5D82AF45-54C8-419F-879A-BBAA10AC8B13Q28391163-C78DE91E-F531-4E2E-A1AE-2D6EF150F3BEQ28391885-3BBBBBE8-527E-47E3-944E-82294F453465Q28392794-F71BD691-0F8C-4BF8-9228-8F1251572772Q28394441-FF9D94D5-96E5-4F64-8234-B69BA43BD352Q28395323-C81141C6-C09B-417C-904A-D84AB585E474Q28396233-EEB0F2A0-D763-40B2-8460-989458F375ADQ28396471-7EAD2DCA-2AC7-4903-A889-EB80919C163EQ28396881-39944981-915E-443D-9100-8A740A84E795Q28543232-BE703F1D-E0F7-4D90-907F-E6444ECCA9A5Q30230898-377A7CD2-C50E-467A-B93F-59F42F44029CQ33509218-4F2DA656-E83B-4821-9163-8911D379B327Q33814824-660A8A83-441D-4FEA-B5F2-E9902F4C46ECQ33824220-620E9BAF-623D-4656-8463-DCD97E818953Q33824233-09DEDD4F-3E0A-45E1-95BA-069AA66DD81FQ33844883-20B70700-B92A-44C9-B908-9E2A5FCE1B8FQ33960685-DCE6BBB6-7518-4844-A783-1B31680325BFQ34287840-D0BC71D8-AEA6-461C-9FBA-5A612A28A35CQ34376228-31C99BE6-BFD4-4E61-BFD4-0FB49ABB880AQ34644088-59FA2EF7-7828-48B9-B00D-93C6213C771AQ34705038-58163C06-0F63-48BF-8510-EF4E4F3FDC9FQ34720827-AC00AB47-40F6-45E2-836E-1A0AA04183EEQ34836888-D8A96C5A-4D7C-410F-8D6C-2C4DA459167BQ34842312-77009848-B4B4-479D-B8B9-8BB1D10228C9Q34952213-537347DF-AFFE-478C-BEB9-C816CF608574Q34999553-2F3BAD5A-093D-439F-B7D3-B92595BCEBEDQ35427989-9B6C0BA0-1236-4753-8146-F5C9E794B154Q35897881-79321356-4092-4419-A0E5-3A667015C20C
P2860
Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Soluble epoxide hydrolase inhi ...... xyeicosatrienoic acids (EETs).
@ast
Soluble epoxide hydrolase inhi ...... xyeicosatrienoic acids (EETs).
@en
type
label
Soluble epoxide hydrolase inhi ...... xyeicosatrienoic acids (EETs).
@ast
Soluble epoxide hydrolase inhi ...... xyeicosatrienoic acids (EETs).
@en
prefLabel
Soluble epoxide hydrolase inhi ...... xyeicosatrienoic acids (EETs).
@ast
Soluble epoxide hydrolase inhi ...... xyeicosatrienoic acids (EETs).
@en
P2093
P2860
P1476
Soluble epoxide hydrolase inhi ...... xyeicosatrienoic acids (EETs).
@en
P2093
Bora Inceoglu
Bruce D Hammock
Christophe Morisseau
Kara R Schmelzer
Steve L Jinks
P2860
P356
10.1016/J.PROSTAGLANDINS.2006.05.004
P577
2006-07-05T00:00:00Z